Indexed keywords
AMANTADINE;
CREATINE KINASE;
DANTROLENE;
PAROXETINE;
PROMETHAZINE;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
ARTICLE;
CASE REPORT;
HUMAN;
MALE;
NEUROLEPTIC MALIGNANT SYNDROME;
SCHIZOPHRENIA;
SEROTONINERGIC SYSTEM;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIPSYCHOTIC AGENTS;
DEPRESSIVE DISORDER;
DRUG THERAPY, COMBINATION;
HEMATOMA, SUBDURAL;
HUMANS;
MALE;
NEUROLEPTIC MALIGNANT SYNDROME;
NEUROLOGIC EXAMINATION;
PAROXETINE;
POSTOPERATIVE COMPLICATIONS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SUICIDE, ATTEMPTED;
1
0023279261
Neuroleptic malignant syndrome: Review and analysis of 115 cases
Addonizio G, Susman VL, Roth SD (1987) Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 22:1004-1020
(1987)
Biol Psychiatry
, vol.22
, pp. 1004-1020
Addonizio, G.1
Susman, V.L.2
Roth, S.D.3
2
0022444461
Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome
Ansseau M, Reynolds CF, Kupfer DJ (1986) Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome. J Clin Psychiatry 47:320-321
(1986)
J Clin Psychiatry
, vol.47
, pp. 320-321
Ansseau, M.1
Reynolds, C.F.2
Kupfer, D.J.3
3
0025133510
Neuroleptic malignant syndrome: A unique association with a tricyclic antidepressant
Baca L, Martinelli L (1990) Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant. Neurology 40:1797-1798
(1990)
Neurology
, vol.40
, pp. 1797-1798
Baca, L.1
Martinelli, L.2
5
0024435195
Fluoxetine and extrapyramidal side effects
Bouchard RH, Pourcher E, Vincent P (1989) Fluoxetine and extrapyramidal side effects. Am J Psychiatry 146:10:1352-1353
(1989)
Am J Psychiatry
, vol.146
, Issue.10
, pp. 1352-1353
Bouchard, R.H.1
Pourcher, E.2
Vincent, P.3
6
0024435195
Fluoxetine and extrapyramidal side effects
Brod TM (1989) Fluoxetine and extrapyramidal side effects. Am J Psychiatry 146:1853
(1989)
Am J Psychiatry
, vol.146
, pp. 1853
Brod, T.M.1
7
0017389926
Possible importance of 5-hydroxy-tryptamine in neuroleptic-induced catalepsy in rats
Carter CJ, Pycock CJ (1977) Possible importance of 5-hydroxy-tryptamine in neuroleptic-induced catalepsy in rats. Proc B P S 267-268P
(1977)
Proc B P S
Carter, C.J.1
Pycock, C.J.2
8
0023955750
Neuroleptic malignant syndrome, amitriptyline, and thioridazine
Corrigan FM, Coulter (1988) Neuroleptic malignant syndrome, amitriptyline, and thioridazine. Biol Psychiatry 23:317-323
(1988)
Biol Psychiatry
, vol.23
, pp. 317-323
Corrigan, F.M.1
Coulter2
9
0020041951
Acute myoglobinuric renal failure, a consequence of the neuroleptic malignant syndrome
Eiser AR, Neff MS, Slifkin RF (1982) Acute myoglobinuric renal failure, a consequence of the neuroleptic malignant syndrome. Arch Intern Med 142:601-603
(1982)
Arch Intern Med
, vol.142
, pp. 601-603
Eiser, A.R.1
Neff, M.S.2
Slifkin, R.F.3
10
0025088416
Fluoxetine and neuroleptic malignant syndrome
Halman M,Goldbloom DS (1990) Fluoxetine and neuroleptic malignant syndrome. Biol Psychiatry 28:518-521
(1990)
Biol Psychiatry
, vol.28
, pp. 518-521
Halman, M.1
Goldbloom, D.S.2
11
0023250427
The neuroleptic malignant syndrome, so-called
Kellam AMP (1987) The neuroleptic malignant syndrome, so-called. Br J Psychiatry 150:752-759
(1987)
Br J Psychiatry
, vol.150
, pp. 752-759
Kellam, A.M.P.1
12
0022370639
Neuroleptic malignant syndrome
Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142:1137-1145
(1985)
Am J Psychiatry
, vol.142
, pp. 1137-1145
Levenson, J.L.1
13
0024246402
Das maligne neuroleptische Syndrom
Pietzcker A (1988) Das maligne neuroleptische Syndrom. Nervenarzt 59:691-700
(1988)
Nervenarzt
, vol.59
, pp. 691-700
Pietzcker, A.1
14
0024334630
A prospective analysis of 24 episodes of neuroleptic malignant syndrome
Rosebush P, Stewart T (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 146:717-725
(1989)
Am J Psychiatry
, vol.146
, pp. 717-725
Rosebush, P.1
Stewart, T.2
15
0022636827
A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome
Schibuk M, Schachter D (1986) A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome. Can J Psychiatry 31:66-69
(1986)
Can J Psychiatry
, vol.31
, pp. 66-69
Schibuk, M.1
Schachter, D.2
16
0024589775
Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine
Tate JL (1989) Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. Am J Psychiatry 146:399-400
(1989)
Am J Psychiatry
, vol.146
, pp. 399-400
Tate, J.L.1
17
0026446484
Pathophysiologie und Therapie des malignen neuroleptischen Syndroms
Weller M, Kornhuber J (1992) Pathophysiologie und Therapie des malignen neuroleptischen Syndroms. Nervenarzt 63:645-655
(1992)
Nervenarzt
, vol.63
, pp. 645-655
Weller, M.1
Kornhuber, J.2